Professional Practice
Overview
Professional practice encompasses the operational and regulatory aspects of working as a genetic counselor within the healthcare system. This chapter covers professional standards, healthcare systems and reimbursement, and public health genetics, topics that address what genetic counselors are authorized to do, how their services are recognized and paid for, how the profession is regulated, and how genetic services reach populations rather than individuals. These topics are directly relevant to daily practice.
The genetic counseling profession has undergone significant changes in recent years, including the expansion of state licensure, the recognition of genetic counselors as healthcare providers for Medicare billing purposes, and the growing scope of practice into new clinical areas such as pharmacogenomics, cardiovascular genetics, and direct patient care roles. Understanding the current professional landscape (including the ABGC practice-based competencies, state licensure requirements, and the evolving relationship between genetic counselors and other healthcare providers) is essential for new graduates entering the workforce.
Insurance and billing knowledge is increasingly expected of genetic counselors who must navigate prior authorizations for genetic testing, understand insurance coverage policies, and in some settings, bill for their own services. Foundational concepts matter more here than memorization of specific billing codes.
Key Concepts
- ABGC practice-based competencies: the framework defining what genetic counselors should be able to do
- State licensure: the growing number of states requiring licensure and its implications for scope of practice and title protection
- Supervision requirements: understanding when and how genetic counselors practice under physician supervision vs. independently
- Prior authorization: the process of obtaining insurance approval for genetic testing before it is ordered
- CPT codes for genetic counseling: awareness of the codes used to bill for genetic counseling services (96041, which replaced 96040 in January 2025, and S0265)
- Genetic testing coverage policies: how insurance companies determine which genetic tests are covered and for whom
- NSGC and ABGC roles: distinguishing between the professional society (NSGC), the credentialing body (ABGC), and the accreditation body (ACGC)
- Population screening principles: the criteria that decide whether a condition belongs in a screening program, and why a positive screen is never a diagnosis
Healthcare Systems
Insurance and Billing covers the practical aspects of genetic test coverage and reimbursement for counseling services. The three payer categories (commercial, Medicare, Medicaid) each have distinct rules, the prior authorization process has its own conventions, and the criteria insurance companies use to determine coverage (medical necessity, clinical guidelines) have implications for both which tests get covered and how they are documented. Denied authorizations, patient cost-sharing, and lab-sponsored financial assistance programs are routine operational concerns. So is the obligation to discuss potential costs with patients before testing is ordered.
Professional Standards
Scope of Practice defines the boundaries and responsibilities of genetic counseling practice as set by professional standards, state laws, and institutional policies. The ABGC practice-based competencies are the core framework. State licensure (where it exists) determines title protection and the legal scope, and the practice landscape continues to evolve with telehealth, mainstreaming models, and laboratory-based roles. Continuing education and the recertification cycle round out the professional-development picture.
Public Health
Population screening asks healthy people a question they did not come in with, which is why it is judged against a different standard than clinical testing. This subsection covers the Wilson and Jungner criteria and why the treatment requirement is contested in genomics, the state-run newborn screening system and what happens after a positive screen, the shift from ancestry-targeted to pan-ethnic carrier screening, and the documented disparities in who reaches genetic services at all. The recurring theme is that a screening program is a system rather than an assay: follow-up, confirmatory capacity, and treatment access decide whether it helps anyone.
Together, these subsections ground the clinical and scientific knowledge from the rest of the section in the practical realities of working within the healthcare system.